MedTrace Logo

Clinical Outcomes Following Treatment With SYSTANE® BALANCE

NCT02776670 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 308

Last updated 2019-06-19

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the clinical effectiveness of SYSTANE® BALANCE compared to REFRESH OPTIVE® Advanced in subjects with lipid-deficient dry eye.

Conditions

  • Dry Eye

Interventions

OTHER

Propylene glycol, 0.6% eye drops

OTHER

Lubricant eye drops

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Clinical Project Manager, PLS · Alcon, a Novartis Company

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-29
Primary Completion
2017-11-22
Completion
2017-11-22

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02776670 on ClinicalTrials.gov